Company to host conference call at 9:30 a.m. ET
today
- Revenue of $40.5 million, up 14.1% year over year
- Gross margin of 35.3%, up 800 basis points year over year;
non-GAAP gross margin of 35.6%, unchanged year over year
- Operating income of $1.1 million; non-GAAP operating income of
$2.2 million
- Net loss per share of $(0.04) vs. $(0.22) in the second quarter
of fiscal year 2024; non-GAAP diluted earnings per share of $0.08
vs. $0.15 in the second quarter of fiscal 2024
- Adjusted EBITDA of $3.9 million, up 5.3% year over year
AstroNova, Inc. (Nasdaq: ALOT), a global leader in data
visualization technologies, today announced financial results for
its fiscal 2025 second quarter ended August 3, 2024.
CEO Commentary
“We demonstrated the resilience of our Product Identification
(PI) and Test & Measurement (T&M) segments during a second
quarter in which we began shipping a previously delayed order and
benefited from the resolution of supply chain shortages,” said Greg
Woods, AstroNova’s President and Chief Executive Officer. “In PI,
total revenue increased more than 5% year-over-year and more than
17% sequentially, driven primarily by organic growth. T&M
revenue grew 37% sequentially and year-over-year, reflecting
continued momentum from our Aerospace product line.
“During the quarter we began the process of integrating our May
acquisition of MTEX NS. Because MTEX was an entrepreneurial,
private company, the integration got off to a slow start in the
quarter, generating revenue of only $0.8 million and an operating
loss of $1.4 million. We expect it to take through the remainder of
fiscal 2025 to transition MTEX’s systems, processes and business
tools to those of the AstroNova Operating System,” Woods said. “We
remain excited about MTEX’s core strengths, including its
engineering and manufacturing capabilities and especially its
game-changing ink and printhead technologies. In the coming months
we will be devoting additional resources to integrating that
technology into more of our Product Identification products. Buoyed
by several large tradeshows since the acquisition, MTEX has built a
strong product backlog that we expect to begin shipping in the
third and fourth quarters, which will enable the business to meet
our target revenue contribution of $8 million to $10 million for
full-year fiscal 2025.”
Business Outlook
“Looking ahead, we are optimistic about our growth prospects,”
Woods continued. “We are well-positioned to continue driving
organic growth, supported by our commitment to delivering
innovative, high-margin products while maintaining strong cost
controls. We anticipate achieving our fiscal year targets for
revenue growth. As a result of the MTEX integration, we have
reduced our consolidated FY 2025 Adjusted EBITDA margin estimate to
a range of 9% to 10% and expect to be within the range of 13% to
14% in fiscal 2026.”
Q2 FY 2025 Financial Results
GAAP
Non-GAAP
($ in thousands except per share
data)
Q2 FY25
Q2 FY24
YoY
Q2 FY25
Q2 FY24
YoY
Revenue
$40,539
$35,524
14.1%
Gross Profit
$14,326
$9,710
47.5%
$14,446
$12,659
14.1%
Gross Margin
35.3%
27.3%
800 pts
35.6%
35.6%
-
Operating Margin
2.6%
(3.4%)
600 pts
5.5%
6.5%
(100 pts)
Net (Loss) Income
$(311)
$(1,617)
-
$572
$1,089
(47.5%)
Net (Loss) Income Per Common
Share
$(0.04)
$(0.22)
-
$0.08
$0.15
(46.7%)
See reconciliation tables GAAP to
Non-GAAP reconciliations.
Adjusted EBITDA was $3.9 million for the second quarter of
fiscal 2025, compared with $3.7 million in the comparable period of
fiscal 2024. Adjusted EBITDA for the fiscal 2025 period excludes
the impact of $1.7 million in costs related to stock-based
compensation, CFO transition and MTEX acquisition-related expenses.
Adjusted EBITDA for the fiscal 2024 period excludes the impact of
stock-based compensation, retrofit and restructuring costs of $3.9
million.
Bookings for the second quarter of fiscal 2025 were $35.8
million compared with $30.1 million in the second quarter of fiscal
2024. Bookings were primarily higher in the Test and Measurement
segment.
Backlog as of August 3, 2024, was $29.9 million, compared with
$31.6 million at the end of the first quarter of fiscal 2025, as
some shipments delayed in the first quarter were shipped in the
second quarter.
Q2 FY 2025 Operating Segment
Results
Product Identification
PI segment revenue was $27.2 million in the second quarter of
fiscal 2025, compared with $25.8 million in the second quarter of
2024, reflecting organic growth and the addition of MTEX NS.
Segment operating profit was $2.3 million, or 8.6% of revenue,
compared with a segment operating loss of $461,000, or (1.8%) of
revenue, in the same period last year. Excluding the results of
MTEX in fiscal 2025 and certain expenses in both periods (see
reconciliation tables below for GAAP reconciliation), non-GAAP
operating profit was $3.6 million, or 13.7% of revenue in the
fiscal 2025 period, compared with non-GAAP operating profit of $3.0
million, or 11.5% of revenue, in the same period of fiscal
2024.
Test & Measurement
Test & Measurement (T&M) segment revenue was $13.4
million in the second quarter of fiscal 2025, compared with $9.7
million in the same period of fiscal 2024, representing a 37.2%
increase. Segment operating profit was $3.8 million, or 28.7% of
revenue, in the second quarter of fiscal 2025 compared with $1.9
million, or 19.7% of revenue, in the second quarter of fiscal 2024.
This improvement reflected higher revenue and $1.3 million in
revenue and $1.0 million in operating profit related to
non-recurring items.
Earnings Conference Call
Information
AstroNova will discuss its fiscal 2025 second quarter financial
results in an investor conference call at 9:30 a.m. ET today. To
access the conference call, please dial (833) 470-1428 (U.S. and
Canada) or (404) 975-4839 (International) approximately 10 minutes
prior to the start time and enter access code 381674. A real-time
and an archived audio webcast of the call will be available through
the “Investors” section of the AstroNova website,
https://investors.astronovainc.com.
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with
generally accepted accounting principles (GAAP), this news release
contains the non-GAAP financial measures non-GAAP gross profit,
non-GAAP gross margin, non-GAAP operating income, non-GAAP
operating margin, non-GAAP net income, non-GAAP net income (loss)
per common share and Adjusted EBITDA. AstroNova believes that the
inclusion of these non-GAAP financial measures helps investors gain
a meaningful understanding of changes in the Company’s core
operating results and can help investors who wish to make
comparisons between AstroNova and other companies on both a GAAP
and a non-GAAP basis. AstroNova’s management uses these non-GAAP
financial measures, in addition to GAAP financial measures, as the
basis for measuring its core operating performance and comparing
such performance to that of prior periods and to the performance of
its competitors. These measures are also used by the Company’s
management to assist with their financial and operating
decision-making. Please refer to the financial reconciliation table
included in this news release for a reconciliation of the non-GAAP
measures to the most directly comparable GAAP measures for the
three months ended August 3, 2024, and July 29, 2023.
AstroNova has not reconciled the forward-looking Adjusted EBITDA
growth percentage included in its 2025 financial targets and
outlook to the most directly comparable forward-looking GAAP
measure because this cannot be done without unreasonable effort due
to the lack of predictability regarding cost of sales, operating
expenses, depreciation and amortization, and stock-based
compensation. The impact of any of these items, individually or in
the aggregate, may be significant.
About AstroNova
AstroNova (Nasdaq: ALOT), a global leader in data visualization
technologies since 1969, designs, manufactures, distributes, and
services a broad range of products that acquire, store, analyze,
and present data in multiple formats.
The Product Identification segment provides a wide array of
digital, end-to-end product marking and identification solutions,
including hardware, software, and supplies for OEMs, commercial
printers, and brand owners. The Test and Measurement segment
provides products designed for airborne printing solutions,
avionics, and data acquisition. Our aerospace products include
flight deck printing solutions, networking hardware, and
specialized aerospace-grade supplies. Our data acquisition systems
are used in research and development, flight testing, missile and
rocket telemetry production monitoring, power, and maintenance
applications.
AstroNova is a member of the Russell Microcap® Index and the LD
Micro Index (INDEXNYSEGIS: LDMICRO). Additional information is
available by visiting https://astronovainc.com/.
Forward-Looking Statements
Information included in this news release may contain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements are not statements of historical fact, but rather
reflect our current expectations concerning future events and
results. These statements may include the use of the words
“believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,”
“continues,” “may,” “will,” and similar expressions to identify
forward-looking statements. Such forward-looking statements,
including those concerning the Company’s anticipated performance,
involve risks, uncertainties and other factors, some of which are
beyond our control, which may cause our actual results, performance
or achievements to be materially different from those expressed or
implied by such forward-looking statements. These risks,
uncertainties and factors include, but are not limited to, (i) the
risk that we may not be able to realize the expected synergies from
our acquisition of MTEX NS, (ii) the risk that apparent
improvements in the Aerospace sector may not continue, (iii) the
risk that supply chain issues may persist longer than we expect,
(iv) the risk that we may not be able to incorporate
customer-requested design enhancements into our products on the
timeframe that we expect or at all, (v) the risk that we may not be
able to ship delayed hardware items on the timeline we expect or at
all, and (vi) those factors set forth in the Company’s Annual
Report on Form 10-K for the fiscal year ended January 31, 2024 and
subsequent filings AstroNova makes with the Securities and Exchange
Commission. The Company undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise. The reader is
cautioned not to unduly rely on such forward-looking statements
when evaluating the information presented in this news release.
ASTRONOVA, INC.
Condensed Consolidated
Statements of Income
In Thousands Except for Per
Share Data
(Unaudited)
Three Months Ended
August 3, 2024
July 29, 2023
Net Revenue
$
40,539
$
35,524
Cost of Revenue
26,213
25,814
Gross Profit
14,326
9,710
Total Gross Profit Margin
35.3
%
27.3
%
Operating Expenses: Selling & Marketing
6,732
6,697
Research & Development
1,412
1,557
General & Administrative
5,121
2,654
Total Operating Expenses
13,265
10,908
Operating Income (Loss)
1,061
(1,198
)
Total Operating Margin
2.6
%
(3.4
)%
Other Expense, net
1,111
809
Income (Loss) Before Taxes
(50
)
(2,007
)
Income Tax Provision (Benefit)
261
(390
)
Net Income (Loss)
$
(311
)
$
(1,617
)
Net Income (Loss) per Common Share - Basic
$
(0.04
)
$
(0.22
)
Net Income (Loss) per Common Share - Diluted
$
(0.04
)
$
(0.22
)
Weighted Average Number of Common Shares - Basic
7,516
7,420
Weighted Average Number of Common Shares - Diluted
7,516
7,420
Six Months Ended
August 3, 2024
July 29, 2023
Net Revenue
$
73,500
$
70,943
Cost of Revenue
47,202
48,847
Gross Profit
26,298
22,096
Total Gross Profit Margin
35.8
%
31.1
%
Operating Expenses: Selling & Marketing
12,388
12,707
Research & Development
3,015
3,345
General & Administrative
8,488
5,780
Total Operating Expenses
23,891
21,832
Operating Income
2,407
264
Total Operating Margin
3.3
%
0.4
%
Other Expense, net
1,711
1,244
Income (Loss) Before Taxes
696
(980
)
Income Tax Provision (Benefit)
(173
)
(211
)
Net Income (Loss)
$
869
$
(769
)
Net Income (Loss) per Common Share - Basic
$
0.12
$
(0.10
)
Net Income (Loss) per Common Share - Diluted
$
0.11
$
(0.10
)
Weighted Average Number of Common Shares - Basic
7,489
7,396
Weighted Average Number of Common Shares - Diluted
7,617
7,396
ASTRONOVA, INC.
Consolidated Balance
Sheets
In Thousands
(Unaudited)
August 3, 2024
January 31, 2024
ASSETS CURRENT ASSETS Cash and Cash Equivalents
$
4,824
$
4,527
Accounts Receivable, net
23,450
23,056
Inventories, net
50,569
46,371
Prepaid Expenses and Other Current Assets
4,218
2,720
Total Current Assets
83,061
76,674
PROPERTY, PLANT AND EQUIPMENT
69,215
57,046
Less Accumulated Depreciation
(50,465
)
(42,861
)
Property, Plant and Equipment, net
18,750
14,185
OTHER ASSETS Intangible Assets, net
27,314
18,836
Goodwill
25,368
14,633
Deferred Tax Assets
10,854
6,882
Right of Use Asset
1,920
603
Other Assets
1,750
1,438
TOTAL ASSETS
$
169,017
$
133,251
LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES Accounts
Payable
$
10,456
$
8,068
Accrued Compensation
3,577
2,923
Other Liabilities and Accrued Expenses
4,369
2,706
Revolving Line of Credit
13,354
8,900
Current Portion of Long-Term Debt
6,513
2,842
Short-Term Debt
3,092
-
Current Portion of Royalty Obligation
1,575
1,700
Current Liability – Excess Royalty Payment Due
798
935
Income Taxes Payable
-
349
Deferred Revenue
785
1,338
Total Current Liabilities
44,519
29,761
NON-CURRENT LIABILITIES Long-Term Debt, net of current portion
22,675
10,050
Royalty Obligation, net of current portion
1,663
2,093
Lease Liability, net of current portion
1,633
415
Grant Deferred Revenue
1,476
-
Contingent Liability Earn Out
1,629
-
Income Tax Payables
551
551
Deferred Tax Liabilities
3,121
99
TOTAL LIABILITIES
77,267
42,969
SHAREHOLDERS’ EQUITY Common Stock
546
541
Additional Paid-in Capital
63,563
62,684
Retained Earnings
64,739
63,869
Treasury Stock
(35,025
)
(34,593
)
Accumulated Other Comprehensive Loss, net of tax
(2,073
)
(2,219
)
TOTAL SHAREHOLDERS’ EQUITY
91,750
90,282
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
$
169,017
$
133,251
ASTRONOVA, INC.
Condensed Consolidated
Statements of Cash Flows
(In Thousands)
(Unaudited)
Six Months Ended
August 3, 2024
July 29, 2023
Cash Flows from Operating Activities:
Net Income (Loss)
$
869
$
(769
)
Adjustments to Reconcile Net Income to Net Cash Provided by
Operating Activities: Depreciation and Amortization
2,216
2,144
Amortization of Debt Issuance Costs
14
11
Share-Based Compensation
806
754
Restructuring - non-cash
-
2,040
Changes in Assets and Liabilities, net of impact of acquisition:
Accounts Receivable
3,612
3,612
Inventories
(384
)
283
Income Taxes
(721
)
(1,461
)
Accounts Payable and Accrued Expenses
2,409
(2,267
)
Deferred Revenue
(619
)
-
Other
(1,136
)
371
Net Cash Provided by Operating Activities
7,066
4,718
Cash Flows from Investing
Activities: Purchases of Property, Plant and Equipment
(830
)
(494
)
Cash Paid for MTEX Acquisition, net of cash acquired
(20,729
)
-
Net Cash Provided (Used) for Investing Activities
(21,559
)
(494
)
Cash Flows from Financing
Activities: Net Cash Proceeds from Employee Stock Option
Plans
13
71
Net Cash Proceeds from Share Purchases under Employee Stock
Purchase Plan
65
54
Net Cash Used for Payment of Taxes Related to Vested Restricted
Stock
(432
)
(350
)
Borrowings under Revolving Credit Facility
3,912
-
Repayment under Revolving Credit Facility
-
(2,000
)
Proceeds from Long-Term Debt Borrowings
15,078
-
Payment of Minimum Guarantee Royalty Obligation
(750
)
(875
)
Principal Payments of Long-Term Debt
(3,274
)
(750
)
Payments of Debt Issuance Costs
(35
)
-
Net Cash Provided (Used) for Financing Activities
14,577
(3,850
)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
213
210
Net Increase in Cash and Cash Equivalents
297
584
Cash and Cash Equivalents, Beginning of Period
4,527
3,946
Cash and Cash Equivalents, End of Period
$
4,824
$
4,530
Supplemental Disclosures of Cash Flow
Information: Cash Paid During the Period for: Cash Paid
During the Period for Interest
$
1,008
$
1,184
Cash Paid During the Period for Income Taxes, net of refunds
$
540
$
1,264
Non-Cash Transactions: Capital Lease Obtained in Exchange for
Capital Lease Liabilities
$
1,455
$
—
ASTRONOVA, INC.
Revenue and Segment Operating
Profit
In Thousands
(Unaudited)
Revenue
Segment Operating
Profit
Three Months Ended
Three Months Ended
August 3, 2024
July 29, 2023
August 3, 2024
July 29, 2023
Product Identification
$
27,165
$
25,777
$
2,348
$
(461
)
Test & Measurement
13,374
9,747
3,834
1,917
Total
$
40,539
$
35,524
6,182
1,456
Corporate Expenses
5,121
2,654
Operating Income (Loss)
1,061
(1,198
)
Other Expense, net
1,111
809
Income (Loss) Before Income Taxes
(50
)
(2,007
)
Income Tax Provision (Benefit)
261
(390
)
Net Income (Loss)
$
(311
)
$
(1,617
)
Revenue
Segment Operating
Profit
Six Months Ended
Six Months Ended
August 3, 2024
July 29, 2023
August 3, 2024
July 29, 2023
Product Identification
$
50,350
$
50,872
$
5,340
$
2,055
Test & Measurement
23,150
20,071
5,555
3,989
Total
$
73,500
$
70,943
10,895
6,044
Corporate Expenses
8,488
5,780
Operating Income
2,407
264
Other Expense, net
1,711
1,244
Income (Loss) Before Income Taxes
696
(980
)
Income Tax Provision (Benefit)
(173
)
(211
)
Net Income (Loss)
$
869
$
(769
)
ASTRONOVA, INC.
Reconciliation of GAAP to
Non-GAAP Items
In Thousands Except for Per Share
Data
(Unaudited)
Three Months Ended
August 3, 2024
July 29, 2023
Gross Profit
$
14,326
$
9,710
Inventory Step-Up
120
-
Restructuring Charges
-
2,096
Product Retrofit Costs
-
852
Non-GAAP Gross Profit
$
14,446
$
12,658
Operating Expenses
$
13,265
$
10,908
MTEX-related Acquisition Expenses
(625
)
-
CFO Transition Costs
(432
)
-
Restructuring Charges
-
(555
)
Non-GAAP Operating Expenses
$
12,208
$
10,353
Operating Income (Loss)
$
1,061
$
(1,198
)
MTEX-related Acquisition Expenses
625
-
CFO Transition Costs
432
-
Inventory Step-Up
120
-
Restructuring Charges
-
2,651
Product Retrofit Costs
-
852
Non-GAAP Operating Income
$
2,238
$
2,305
Net Income (Loss)
$
(311
)
$
(1,617
)
MTEX-related Acquisition Expenses, net
470
-
CFO Transition Costs, net
328
-
Inventory Step-Up, net
85
-
Restructuring Charges, net
-
2,048
Product Retrofit Costs, net
-
658
Non-GAAP Net Income
$
572
$
1,089
Diluted Earnings (Loss) Per Share
$
(0.04
)
$
(0.22
)
MTEX-related Acquisition Expenses
0.06
-
CFO Transition Costs
0.05
-
Inventory Step-Up
0.01
-
Restructuring Charges
-
0.28
Product Retrofit Costs
-
0.09
Non-GAAP Diluted Earnings (Loss) Per Share
$
0.08
$
0.15
Six Months Ended
August 3, 2024
July 29, 2023
Gross Profit
$
26,298
$
22,096
Inventory Step-Up
120
-
Restructuring Charges
-
2,096
Product Retrofit Costs
-
852
Non-GAAP Gross Profit
$
26,418
$
25,044
Operating Expenses
$
23,891
$
21,832
MTEX-related Acquisition Expenses
(625
)
-
CFO Transition Costs
(432
)
-
Restructuring Charges
-
(555
)
Non-GAAP Operating Expenses
$
22,834
$
21,277
Operating Income
$
2,407
$
264
MTEX-related Acquisition Expenses
625
-
CFO Transition Costs
432
-
Inventory Step-Up
120
-
Restructuring Charges
-
2,651
Product Retrofit Costs
-
852
Non-GAAP Operating Income
$
3,584
$
3,767
Net Income (Loss)
$
869
$
(769
)
MTEX-related Acquisition Expenses, net
470
-
CFO Transition Costs, net
328
-
Inventory Step-Up, net
85
-
Restructuring Charges, net
-
2,048
Product Retrofit Costs, net
-
658
Non-GAAP Net Income
$
1,752
$
1,937
Diluted Earnings (Loss) Per Share
$
0.11
$
(0.10
)
MTEX-related Acquisition Expenses
0.06
-
CFO Transition Costs
0.05
-
Inventory Step-Up
0.01
-
Restructuring Charges
-
0.28
Product Retrofit Costs
-
0.09
Non-GAAP Diluted Earnings Per Share
$
0.23
$
0.27
ASTRONOVA, INC. Reconciliation of GAAP to Non-GAAP
Items for PI Segment Amounts In Thousands (Unaudited)
Q2 FY25 Q2 FY24 Total PI Segment as Reported MTEX As
Reported Inventory Step Up Adj MTEX (Non Gaap) PI Excluding MTEX
(Non Gaap) Total PI Segment as Reported Restructuring and Product
Retrofit Adjustments Total PI Segment (Non Gaap) Sales
$
27,165
$
768
$
-
$
768
$
26,397
$
25,777
$
-
$
25,777
Cost of Revenue
18,544
836
(120
)
716
17,828
19,487
(2,948
)
16,539
Gross Profit
8,621
(68
)
120
52
8,569
6,290
2,948
9,238
Operating Expenses
6,273
1,328
-
1,328
4,945
6,751
(472
)
6,279
Segment Operating Profit
$
2,348
$
(1,396
)
$
120
$
(1,276
)
$
3,624
$
(461
)
$
3,420
$
2,959
ASTRONOVA, INC.
Reconciliation of Net Income
(Loss) to Adjusted EBITDA
Amounts In Thousands
(Unaudited)
Three
Months Ended
August 3, 2024
July 29, 2023
Net Income (Loss)
$
(311
)
$
(1,617
)
Interest Expense
938
674
Income Tax Expense (Benefit)
261
(390
)
Depreciation & Amortization
1,305
1,089
EBITDA
$
2,193
$
(244
)
Share-Based Compensation
481
398
MTEX-related Acquisition Expenses
625
-
CFO Transition Costs
432
-
Inventory Step-Up
120
-
Restructuring Charges
-
2,651
Product Retrofit Costs
-
852
Adjusted EBITDA
$
3,851
$
3,657
Six Months
Ended
August 3, 2024
July 29, 2023
Net Income (Loss)
$
869
$
(769
)
Interest Expense
1,419
1,289
Income Tax Expense (Benefit)
(173
)
(211
)
Depreciation & Amortization
2,216
2,144
EBITDA
$
4,331
$
2,453
Share-Based Compensation
806
754
MTEX-related Acquisition Expenses
625
-
CFO Transition Costs
432
-
Inventory Step-Up
120
-
Restructuring Charges
-
2,651
Product Retrofit Costs
-
852
Adjusted EBITDA
$
6,314
$
6,710
ASTRONOVA, INC.
Reconciliation of Segment
Operating Income (Loss) to Non-GAAP Operating Income
Amounts In Thousands
(Unaudited)
Three Months Ended
August 3, 2024
July 29, 2023
Product Identification
Test & Measurement
Total
Product Identification
Test & Measurement
Total
Segment Operating Profit (Loss)
$
2,348
$
3,834
$
6,182
$
(461
)
$
1,917
$
1,456
Inventory Step-Up
120
-
120
-
-
-
Restructuring Charges
-
-
-
2,568
-
2,568
Product Retrofit Costs
-
-
-
852
-
852
Non-GAAP - Segment Operating Profit
$
2,468
$
3,834
$
6,302
$
2,959
$
1,917
$
4,876
Six Months Ended
August 3, 2024
July 29, 2023
Product Identification
Test & Measurement
Total
Product Identification
Test & Measurement
Total
Segment Operating Profit
$
5,340
$
5,555
$
10,895
$
2,055
$
3,989
$
6,044
Inventory Step-Up
120
-
120
-
-
-
Restructuring Charges
-
-
-
2,568
-
2,568
Product Retrofit Costs
-
-
-
852
-
852
Non-GAAP - Segment Operating Profit
$
5,460
$
5,555
$
11,015
$
5,475
$
3,989
$
9,464
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240916638067/en/
Scott Solomon Senior Vice President Sharon Merrill Advisors
(857) 383-2409 ALOT@investorrelations.com
AstroNova (NASDAQ:ALOT)
Historical Stock Chart
From Oct 2024 to Nov 2024
AstroNova (NASDAQ:ALOT)
Historical Stock Chart
From Nov 2023 to Nov 2024
